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Abstract 
Engineering the Production of Itaconic Acid 
in Escherichia coli 
by 
Tao Lin 
Itaconic acid (IA) has many versatile applications in science and medicine. Engineering 
Escherichia coli can provide a reliable route for IA production, where cis-aconitate 
decarboxylase (CAD) is one essential enzyme in the process. The synthetic cad gene has been 
cloned into various vectors to improve the expression rate and folding activities. The strain 
bearing plasmid pTrc99a-cad displays a significant amount of IA production, while the CAD 
protein expressed from the same plasmid displays the highest enzymatic activity in vitro. To 
improve the reliability of forming the cis-aconitate intermediate, the aconitase genes from 
Aspergillus terreus have been cloned into the pTrc99a vector. The expression of aconitate 
hydratase leads to a peak at 10.3 min in the HPLC spectra after 4 hours incubation. The peak will 
be analyzed to determine whether it is cis-aconitate. The obtained data will provide data on 
possible metabolic pathways of IA production in Aspergillus terreus. 
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CHAPTER 1 Introduction 
1.1 Overview 
The main purpose of my study is to utilize various techniques in molecular biology, such 
as cloning, enzymatic assays, and shake flash fermentation, to analyze and enhance the 
production of useful biomolecular compounds. In particular, my study concentrates on 
engineering Escherichia coli (E. coli) to generate itaconic acid (IA) by introducing the exotic 
genes from Aspergillus terreus (A. terreus). Previous research has shown that cis-aconitate 
decarboxylase (CAD) from A. terre us is one key enzyme to catalyze the conversion of cis-
aconitate to IA; hereby, my goal is to over-express synthetic cad gene in E. coli strains. To 
bolster the availability of cis-aconitate, the aconitase (acn) genes from A. terre us are introduced 
and analyzed in E. coli strains. Various vectors would be employed to examine expression of 
these genes. By analyzing the metabolites produced, as well as enzymatic activities of genes in 
these vectors, I could investigate production of IA in E. coli. 
1.2 Project Objectives 
The primary objective of this study was the application of strategic pathway design to 
improve the production of itaconic acid in E. coli. As shown in Figure 1.1, the initial approach 
was to over-express the cad gene by cloning this gene in various vectors and analyzing the 
enzymatic activities both in vivo and in vitro. High activity and quantity of CAD protein would 
enhance the conversion of cis-aconitate into itaconate. This expectation would require sufficient 
amount of cis-aconitate to be accumulated inside the cytoplasm. But the aconitases in E. coli 
usually bind cis-aconitate inside their active sites without releasing this intermediate in the TCA 
cycle. Therefore, the introduction of an exotic aconitase from A. terre us was necessary to boost 
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the supply of cis-aconitate. Four potential aconitase genes from A. terreus were identified 
through BLASTing Aspergillus niger 3] 8.55 aconitase genes with the entire genomic DNA of A. 
terreus NIH2426. Testing these potential aconitase genes might allow us to identify a unique 
aconitase that specifically converts citrate into cis-aconitate, increasing the supply of the 
intermediate. Beyond cloning these genes, I also planned to delete the branch pathways of 
pyruvate and acetyl-CoA to increase the flux of oxaloacetate. As a result, these actions would be 
expected to improve the production of IA. 
Glucose 1 Glycolysis 
PEP 
1 
Acetate 
Pyruvate 
~1 Lactate Idh NAD+ NADH 
ATP Acetyl- CoA 
ADP ~l Ethanol 
~ ~H~COOH Oxaloacetate HO COOH Citrate 
/ 
COOH 
TCA cycle \. \ cnA or 8 
Fumarate Acn \ 
r 
COOH CAD [COOH 
Cis-aconitate E~OOH ----~) [lCOOH 
Malate ·COOH ~ 
.J Itaconate \ ,. AcnA or B ·C02 
H0=tCOOH Succinate H COOH Isocitrate 
~COOH 
Figure 1.1 - Proposed strategy to increase the main flux of glycolysis and the TeA cycle in 
E. coli. 
_ --Gene knockout; --+ -- the increased flux of pathway; Acn - aconitase from other 
species. 
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1.3 Background 
1.3.1 Characteristics and applications of IA 
formula: CsO.U. 
Molecular weight: 130.1 
Melting point: 167-161 °c 
Boiling point: 268 °c 
Water solubility: 83.103 giL 
Density: J .632 gIL (20"C) 
pll c 2 (aqueous solution at ~) 
pK. '" 3.84 and S.SS 
Figure 1.2 - The structure and properties of itaconic acid (Willke and Voriop, 2001) 
Itaconic acid (IA) is a white crystalline dicarboxylic acid with the double bond that is 
conjugated to one carboxyl group (See Figure 1.2) (Willke and Voriop, 2001). Its characteristics 
and potential reactions have been well reviewed by Tate (Tate, 1970)_ The double bond structure 
enables IA to be easily polymerized to fonn sophisticated complexes, while the two carboxyl 
groups contribute to effective acidic functionality. These characteristics allow IA to serve in 
many versatile applications in industry, agriculture, pharmacy, and medicine (Okabe et aI., 
2009). For instance, the polymerized methyl, ethyl, or vinyl fonns of itaconate have been widely 
used in oral drug-delivery (Betancourt et al.; Teijon et aI., 2009), dental glass-ionomer cements 
(Coutinho et aI., 2009; Moshaverinia et aI., 2009), water resistant resins (Zhao et aI., 2004), and 
so on. The common detergents, cleaners, and other related products also utilize IA in their 
ingredients (Lancashire, 1969). Furthennore, with the depletion of petroleum resources, IA can 
substitute for petroleum derived products, such as acrylic or methylacrylic acid (Willke and 
Voriop, 2001), and also serve as a precursor for many useful chemicals (Ltd, 2008). Thus, the 
investigations into new properties of IA have provided more possibilities for novel applications 
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in various fields. IA has been categorized as one of the twelve most important renewable 
chemicals by the United States Department of Energy (Ltd, 2008). Each year, more than eighty 
thousand tons of IA are produced in the world (Okabe et aI., 2009). Although the price of IA has 
dropped from $4.3 US dollars (Willke and Vorlop, 2001) to $2 US dollars per kilogram (Okabe 
et aI., 2009) in ten years, the continuously growing market demands the production of IA with 
higher efficiency and lower production costs. 
1.3.2 Industrial production of IA and IA producing strains 
Chemical synthesis methods for IA have been developed since 1943 (Blatt, 1943), but 
none of these processes has been practiced commercially due to expensive production costs. 
Instead, the main route for production of IA is via fermentation of A. terreus. Since the first plant 
was established by Pfizer Co. Inc. (Pfeifer et aI., 1952), many efforts have been made to optimize 
the production of IA on a large scale, including strain selections, fermentation process 
manipulations, various substrate utilizations, and so on (Okabe et aI., 2009). For instance, Yahiro 
et ai. treated the parent strain, A. terre us IFO-6365, with N-Methyl-N'-nitro-N-nitrosoguanidine 
(NTG) and selected the high-producing strain, A. terre us TN-484-Ml. The selected stain can 
produce 82 gil of IA from 160 gil of glucose in a shaking flask in 6 days (Yahiro et aI., 1995). To 
improve the economics of fermentation processes, various kinds of bioreactors have been tested 
to compete for the higher efficiency of IA production, including bubble column, packed bubble 
column, tubular reactor, and air-lift reactor (Okabe et aI., 2009). Moreover, other inexpensive 
alternative feedstocks, such as corn steep liquor and glycerol (Jarry and Seraudie, 1995), have 
been reported in industrial fermentations to further reduce costs. Although A. terre us has been 
commonly used in commerce, many other organisms have been explored for the production of 
IA. For instance, Aspergillus itaconic us was first isolated to produce IA for industrial uses 
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(Kinoshita, 1932). Usti/ago and Candida species also produce IA from glucose (Panakova, 2009; 
Tabuchi, 1991, 1980; Tabuchi et aI., 1981). In this project, we are interested in exploring the 
possibilities of E. coli for IA production. 
1.3.3 Metabolic pathway of IA production in A. terreus 
To engineer E. coli to produce lA, it is essential to understand the biosynthesis of IA in 
fungi. For decades, scientists proposed various theories of IA production in fungal cells (Bentley 
and Thiessen, 1957a; Eimhjellen and Larsen, 1955; Kinoshita, 1932; Shimi and Nour EI Dein, 
1962). Most accumulated evidence supports that the production of IA is mainly via the Embden-
Meyerhof-Pamas (EMP) pathway and the tricarboxylic acid (TCA) cycle. In general, glucose is 
dissimilated to pyruvate through the EMP pathway. Then pyruvate is transported to the 
mitochondria and converted to acetyl-CoA, which combines with oxaloacetate to form citrate. 
Through catalysis of aconitase, citrate is dehydrated to cis-aconitate that is further catalyzed to 
itaconate by cis-aconitate decarboxylase (CAD) (see Figure 1.3). In early research, Bentley and 
Thiessen showed that A. terre us NRRL 1960 utilized 14C label glucose to produce IA via citrate 
(Bentley and Thiessen, 1957a, b). More importantly, cis-aconitate could be converted to IA via a 
crude protein extract of A. terreus that contains cis-aconitate decarboxylase (CAD) (Bentley and 
Thiessen, 1957c). Later, Winskill showed that citrate synthase was highly active during both the 
growth and production phases, whereas isocitrate dehydrogenase activity was high in the growth 
path but decreased to 1/8th that value in the production phase. Furthermore, incorporation of[ 1-
14C] acetate and [2-14C] acetate supports the production of IA via the TCA cycle (Winskill, 
1983). Later, Bonnarme et ai. confirmed that pyruvate is dissimilated into cis-aconitate, which is 
then decarboxylated to itaconate, and verified the model proposed by Bentley and Thiessen 
(Bonnarme et aI., 1995). However, the exact metabolic pathway of itaconic acid has not been 
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fully completed due to two factors. As shown in Figure 1.3, the biosynthesis route seems to 
occur both in the cytosol and mitochondria (Jaklitsch et aI., 1991). Many microorganisms contain 
isoforms of key enzymes involved in biosynthesis, such as aconitases (Beinert and Kennedy, 
1993a; Van Der and Caspers, 2007) . Therefore, future work is needed to verify the entire 
pathway. 
Glucose 
I 
I 
t 
I cytoso/l 
pyruvate ------( 
+ o xaloacetate--"L-M 
Citrate .... - ...... =---"""""'--t. 
9+2 
C;s-Acoln~!~ - - - -
3 ~jt~conate (7) 
,P ••• S 
ltaconate 
ITACONIC ACID 
I Mitochondrion I 
Pyruvate ..... Acetyl-CoA ~1 
L-IVlIGIG'lU -Oxaloacelate 1 
}O-~--------- Citrate 
9.2 
- - - - - cis-Aconitate 
+2 
Isocltrate 
I Extracellular medium I 
Figure 1.3 - Postulated biosynthesis route(s) for itaconic acid in A. terre us. 
1, Citrate synthase; 2, Aconitase; 3, cis-aconitic acid decarboxylase (itaconate-forming); 4, cis-
aconitic acid decarboxylase (citraconate-forming); 5, citraconate isomerase; 6, mitochondrial 
dicarbocylate-tricarbocylate antiporter; 7, mitochondrial tricarboxylate transporter; 8, 
dicarbocylate transporter; 9, 2-methyIcitrate dehydratase. (Van Der and Caspers, 2007) 
1.3.4 Characteristics of cis-aconitate decarboxylase (CAD) 
According to Figure 1.3, two enzymes, cis-aconitate decarboxylase (CAD) and aconitase 
(Acn), are crucial for the biosynthesis of IA. Although CAD was discovered in celllysates of A. 
terreus (Bentley and Thiessen, 1955), CAD was not isolated as homogeneous protein until 2002 
(Dwiarti et aI., 2002). CAD has a size of 55 kDa and shows optimal pH and temperatures of 6.2 
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and 37°C, respectively. This enzyme has a Km value for cis-aconitate of 2.45 mM at the optimal 
conditions. Moreover, IA production correlates with CAD activity, meaning that CAD is 
essential to IA production (Dwiarti et aI., 2002). The ATEG_09971 gene (cadi) from A. terreus 
NIH2624 was confirmed to encode CAD and the transformed cadi gene expressed functional 
protein in yeast. More importantly, a transcription assay of cadi showed that a high-producing 
strain had a higher expression level of cadi while itaconic acid has no apparent inhibitory effect 
on the transcription rate (Kanamasa et aI., 2008). 
1.3.5 General information about aconitases (Acn) 
The other key enzyme is aconitase that catalyzes the reversible inter-conversion of citrate 
to isocitrate via cis-aconitate in the TCA cycle, where the [4Fe-4S] cluster is required for the 
binding of these substrates at the catalytic site (Beinert and Kennedy, 1993b). The aconitase 
family includes five discrete functional subgroups: (1) mitochondrial aconitase (mAcn); (2) 
fungal and bacterial isopropylmalate isomerases (IPMI); (3) homoaconitases; (4) iron regulatory 
proteins (IRP) and bacterial aconitase As (AcnA); (5) bacterial aconitase Bs (AcnB) (Oruer et aI., 
1997a; Williams et aI., 2002). Eukaryotic mitochondrial aconitases mainly catalyze the second 
and third steps of the TCA cycle (Shadel, 2005). The X-ray structure of porcine heart mAcn was 
first determined with isocitrate bound to the [4Fe-4S] cluster (Lauble et aI., 1992). Further, 
crystal structures of mAcn with the inhibitors trans-aconitate and nitrocitrate bound to the iron-
sulfur cluster were reported and the combined results support the proposed mechanism of 
aconitase activity. As shown in Figure 1.4, citrate is dehydrated by aconitase to form cis-
aconitate; cis-aconitate rotates 180° around an axis perpendicular to the double bond at the 
catalytic site. Next, the flipped cis-aconitate will be hydrated by aconitase to form isocitrate 
(Lauble et aI., 1994). 
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CITRATE cis-ACONITATE 
OH y 
COO-
COO- ± H2O ~ 
H a. 
" H 
H* 
II flip 
OH 
H 
COO-COO- a. 
" 
a 
±H2O 
H* 
(2R,3S) ISOCITRATE 
Figure 1.4 - The general mechanism of aconitase catalysis. 
In general, the hydroxyl group and the proton from citrate are removed by aconitase to from cis-
aconitate. Next, cis-aconitate rotates 1800 around an axis perpendicular to the double bond. Next, 
cis-aconitate is further hydrated to form isocitrate. (Lauble et aI., 1994) 
The mAcn consists of 4 domains, where domain 4 is connected to domain 3 with a 
flexible linker (see Figure 1.5) (Lauble et aI., 1992). Twenty amino acids were identified to be 
involved in the aconitase catalytic function: seven residues in domains 1,2 and 3 are involved in 
substrate recognition; six in domains I, 2 and 4 interact with the iron-sulfur cluster; seven in 
domains I, 2 and 4 catalyzed the reaction (Frishman and Hentze, 1996; Gruer et aI., 1997a). Site 
mutation analysis shows that ArgS80 is critical in substrate binding; ASplOO and His\Ol eliminate 
the hydroxyl group from substrates; Ser642 functions as proton donor or acceptor (Zheng et aI., 
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1992). In contrast, IMPI is involved in the leucine biosynthesis pathway (Frishman and Hentze, 
1996), whereas homoaconitase is found only in Saccharomyces cerevisiae (Gruer et aI., 1997a). 
Depending on the conditions of iron availability and stress, IRP either regulates the translation of 
iron metabolism genes or functions as a cytosolic aconitase (Volz, 2008). 
a 
c 
3 4 
123 4 
b 
N _ _ ~=--=::::J 
5 4 1 2 3 
Figure 1.5 - Structure of AcnB. 
(a) The structure of bovine mAcn (PDB, lACO). This structure contains 4 domains, where domain 
4 is joined with domain 3 with a linker. Trans-aconitate is located in the active-site cleft. (b) The 
structure of AcnB. This structure contains 5 domains, where domain 4 is linked to domain 1 with a 
linker. An additional 5th domain is connected with domain 4. (c) Comparison of the 4 domains of 
mAcn and AcnB. The domains match well, but some regions of domains separate apart. Adopted 
from (Williams et aI., 2002). 
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1.3.6 Aconitases in E. coli 
E. coli cells possess two 
Table 1 - Enzymatic activities of AcnA and AcnB 
Enzyme Substrate KID (mM) Substrate KID (mM) major distinct aconitases, AcnA and 
AcnA Citrate 1.16 cis -aconitate 0.058 
AcnB Citrate 11 cis-aconitate 0.016 AcnB (Gruer and Guest, 1994). Both 
Adapted from Brenda Enzyme Database proteins require a [4Fe-4S] for their 
function (Jordan et aI., 1999) and are highly regulated by various enzymes (Cunningham et aI., 
1997). Both of them can utilize citrate and cis-aconitate as substrates to produce cis-aconitate 
and isocitrate, respectively (Table 1) The AcnB is the major TCA cycle enzyme during 
exponential growth, whereas the AcnA is expressed in the stationary phase or under stress 
conditions (Cunningham et aI., 1997; Gruer et aI., 1997b). Like mAcn, AcnA has 4 domains and 
displays the highest identity (53%) with iron regulatory factor (lRF) (see figure 4a) (Bennett et 
aI., 1995). In contrast, AcnB represents a unique bacterial aconitase and possesses an extra N-
terminal fifth domain, which resembles a HEAT (Hungtingtin-Elongation-A subunit-TOR) 
domain (Williams et aI., 2002). The HEAT-like domain not only facilitates the 
homodimerization of AcnB, but also assists in post-transcriptional regulation of gene expression 
(Tang et aI., 2005; Williams et aI., 2002). In addition, both aconitases in E. coli are sensitive to 
superoxide (Gardner and Fridovich, 1991, 1992), nitric oxide (Gardner et aI., 1998; Gardner et 
aI., 1997), and iron depletion (Varghese et aI., 2003). 
1.3.7 The 2-Methylcitrate dehydratase from Shewanella oneidensis (S. oneidensis) 
Beyond the major aconitases mentioned above, a special enzyme called 2-methylcitrate 
dehydratase that participates in the propionic acid cycle (Brock et aI., 2002; Horswill and 
Escalante-Semerena, 1999). As shown in Figure 1.6, with the help of accessory protein PrpF, 
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acnO could only convert 2-methylcitrate to 2-methylcitrate isocitrate, which is further catalyzed 
by AcnB to produce 2-methylisocitrate. 
Ptopion.... a...I: 
+ CoA .-,.,.. 
+ATP l 
PPj 
PrpB 
+ 
J¥UV* 
Figure 1.6 - Schematic representation of the 2-mehtylcitraic acid cycle with an emphasis on 
the chemical transformations catalyzed by either PrpD or AcnDlPrpF. (Garvey et aI., 2007) 
Substrate AcnD AcnA 
Citrate 2.9 ± 0.5 26.5 ± 4.0 
cis-Aconitate 5.0± 0.2 68.5 ± 7.4 
Isocitrate NO 43.4± 3.1 
2-Methylcitrate 7.8 ± 0.4 NO 
2-Methylisocitrate NO 12.7 ± 1.4 
Table 2 - Specific activity of AcnD and AcnA with different substrates (Grimek and 
Escalante-Semerena,2004). 
NO - No detectible activity observed under the conditions tested. Specific activities were 
reported in micromoles per minute per milligram of protein and calculated from the extinction 
coefficients of 3,600 M- I cm- I for the cis-aconitate and 4,500 M- I cm- I for the 2-methyl-cis-
aconitate. 
More interestingly, the AcnO from Shewanella oneidensis (S. oneidensis) shows no 
enzymatic activity with isocitrate, but can utilize citrate or cis-aconitate in vitro tests compared 
to AcnA from E.coli (Table 2) (Grimek and Escalante-Semerena, 2004). Furthermore, AcnD 
requires the accessory protein PrpF for its function (Grimek and Escalante-Semerena, 2004). X-
ray structure and in vitro analysis shows that PrpF isomerizes trans-aconitate to cis-aconitate, 
which serves as a substrate for AcnB in the propionic acid pathway (Garvey et aI., 2007). Protein 
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sequence alignment between AcnD and porcine heart aconitase (mAcn) shows that AcnD 
possesses 18 of 20 conserved active residues, whereas Gln72 and Arg580 are switched to His 
and Asp, respectively. Gln72 and Arg580 are crucial for substrate binding (Lauble et aI., 1992); 
they interact with one pair of oxygen atoms in the Oy carboxyl group of isocitrate (Lauble et aI., 
1994). These mutations may cause the enzyme to lose the contact with isocitrate and may explain 
why AcnD shows no activity with isocitrate. Future research is required to confirm this finding. 
1.3.8 Debate on the existence of citrate dehydratase 
To gain more knowledge about this special A. terre us aconitase, we choose to study the 
aconitase from A. niger as an initial alternative. A. niger is a well-known fungus that is used to 
produce citric acid commercially, another intermediate during the biosynthesis of itaconate. A. 
niger and A. terre us are evolutionarily closed-related and share many identities. Importantly, 
early publications provided us with some preliminary data on A. niger aconitase. Neilson 
reported that the citrate dehydratase ("aconitic hydratase") in A. niger strain 72-4 mainly 
performed the inter-conversion of citrate and cis-aconitate. (Neilson, 1955, 1956) However, La 
Nauze disagreed with this idea The experimental results showed that the activities of aconitase 
didn't differ greatly in the reaction of citrate~cis-aconitate or isocitrate~cis-aconitate. The 
aconitase remained active during the entire fermentation and the concentration of ferrous ion 
affected the aconitase activity. (La Nauze, 1966) La Nauze's conclusions were further supported 
by findings of Kubicek and Rohr. They could not detect citrate dehydratase in their A. niger. 
(Kubicek and Rohr, 1985) Although the same strain of A. niger was used, Neilson and La Nauze 
used different methods to perform their research. The Kubicek group applied similar techniques 
as the La Nauze group, but different strains of A. niger were used during the research. Thus, it 
will be curious to see if A. niger has a special citrate hydratase. 
12 
1.3.9 Sequence analysis of potential aconitases from A. terre us 
Currently, no A. terreus aconitases participating in the biosynthesis of IA have been 
reported in the databases. Beyond producing itaconic acid, a mutant strain of A. terre us has been 
patented for production of cis-aconitic acid (Holdom and Winskill, 1988). We suspect the cad 
gene in this strain may have become nonfunctional. Consequently, A. terreus accumulates the 
intermediate, cis-aconitate, without further degradation. As shown in Figure 1.7, bioinformatics 
analysis shows that 4 hypothetical aconitase genes are can be detected in A. terre us NIH2624: 
ATEG_03325 (mitochondrial precursor) and ATEG_08913 (cytosolic precursor) under non-
itaconic acid producing conditions; ATEG_02937 (mitochondrial precursor) and ATEG_05743 
(cytosolic precursor) under itaconic acid producing conditions . 
• Under non-itaconic acid production 
(hypothetical) 
ATEG_02937 
1095AAs 
ATEG_03325 
781 AAs 
• Under itaconic acid production (hypothetical) 
ATEG_05743 
401 AAs 
ATEG_08913 
812AAs 
Figure 1.7 - Four candidate aconitase genes from Aspergillus terre us NIH2624. 
The genes ATEG_02937 and ATEG_03325 are expected to express under the condition of non-
itaconic acid production; the genes ATEG_05743 and ATEG_08913 are expected to express 
under the conditions of itaconic acid production. 
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Protein sequence alignment between S. oneidensis AcnD and A. terreus NIH2624 
genome reveals that ATEG_03325 encoding for XP _001212503 shows the best identity with 
AcnD (188 hits) and reserved all the residues at the active site (Frishman and Hentze, 1996). On 
the other hand, ATEG_02937 encoding for XP_001212115 is the second most identical (166) to 
AcnD; it conserved 18 residues at its active residues while ArgS80 and Ser643 are changed to Lys 
and Ala, respectively. ArgS80 is thought to participate in the 1800 flip of cis-aconitate in the active 
site, whereas Ser643 interacts with the C(3 carboxyl group of isocitrate (Lauble et aI., 1992). These 
mutations may cause the enzyme to only dehydrate citrate and allow the A. terre us to accumulate 
cis-aconitate without consuming it. Therefore, cloning ATEG_02937 is of interest to pursue in 
the research. 
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CHAPTER 2. Materials and Methods 
This Chapter describes the materials and methods used to perform the research presented 
in this work. 
2.1 Strains and plasm ids 
The strains and plasmids utilized during the research are listed in Table 2 and 3. 
Table 3 - List of strains and plasmids used in this research 
Strain 
GNB 11338 
GNB 11339 
GNB 10257 
TOP 10 
GNB 11315 
GNB 11321 
BL21 
XLI-Blue 
Plasmid 
pTrc99a 
pTrcHis 
pDHC29 
pET32a 
pThioHisB 
pPRP140 
pTrc99a-cad 
Significant Genotype 
AacnB736::kan 
AacnA785::kan 
Wild type, = MG1655 
rpsL(Su-R) 
Chromosomal P ara-groELIS 
Chromosomal P AI/laco_l-dnaK/J-lacfl 
lacI lacUV5-T7 gene 
Tnl0 (TeO 
Genotype 
Cloning vector, Apt{: 
Cloning vector, ApR 
Cloning vector, CmR 
Cloning vector, ApR 
Cloning vector, ApR 
Cloning vector, ApR 
Synthetic cad gene inserted into pTrc99a vector 
Table 4 - List of Fungi in this project 
Strain Reference 
References 
(Baba et ai, 2006) 
(Baba et ai, 2006) 
This Study 
Invitrogen 
(Guisbert et aI., 2004) 
(Guisbert et aI., 2004) 
Promega 
Stratagene 
References 
Pharmacia 
Invitrogen 
(Philips et aI., 2000) 
EMD 
Invitrogen 
(Grimek and Escalante-
Semerena, 2004) 
This Study 
Aspergillus niger DSM 872 German Collection of Microorganisms and Cell Cultures 
As r illu te"eus NIH2624 Fun al Genetic Stock Center 
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2.2 Media 
2.2.1 LB medium and Aspergillus medium 
Luria Bertani (LB) broth medium was prepared by mixing 10 gIL tryptone, 5 gIL yeast 
extract, and 10 gIL NaCI in distilled water. LB medium was supplemented with carbon sources 
such as glucose, cis-aconitate, and citrate in various concentrations specific to the experiments. 
The LB medium was autoclaved and the carbon sources were filter-sterilized and added 
afterwards. 
Antibiotics were added to the final concentrations of 100 ng/mL ampicillin, 50 ng/mL 
kanamycin, and 35 ng/mL chloramphenicol to select the strains and plasmids with antibiotic 
resistance. Isopropyl-p-thiogalactopyranoside (IPTG) was added to a final concentration of 1 
mM to induce genes under control of the pTrc promoter. Arabinose was added to a final 
concentration of 500 ng/f.'L and to induce genes under control of the pBAD promoter. 
Aspergillus complete medium (CM) was prepared by following the protocol from Dr. 
May's Lab (M.D. Anderson Cancer Center, Houston, TX). In this protocol, sodium nitrate is 
replaced by ammonium tartrate in the protocol. (See Appendix) 
2.2.2 Storage Medium 
2.2.2.1 Glycerol stocks 
Glycerol stocks were prepared to store the E. coli strains for long term storage. These 
stocks consisted of 500 f.'L of filter-sterilized 40% glycerol and 500 f.'L of overnight cultures. 
After mixing the cells by vortexing, the stock was left at room temperature for 1 hr, and then 
stored in the block at -80°C. For Aspergillus species, the glycerol stocks consist of 500 f.'L of 
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filter-sterilized 10% glycerol and 500 JlL of collected spores. After mixing the spores by 
vortexing, the stock was quickly frozen by liquid nitrogen, and then stored in the block at -80°C. 
2.2.2.2 Agar plates 
Agar plates were prepared by mixing LB or CM medium with 15 gIL technical agar. 
After autoclaving, the agar mixture was cooled to around 55°C before addition of the proper 
antibiotic, IPTG, arabinose, and so on whenever required. Cells were selected on the plates and 
stored in refrigerator for a short period of time. 
2.3 Cell Cultivation 
2.3.1 Overnight aerobic tubes 
A single colony of E. coli from the LB agar plate or the glycerol stock was inoculated in 
5 mL LB medium with appropriate antibiotic. The cultures were grown in the shaker at 30 or 37 
°C at 250 rpm. 
2.3.2 Collect the spores from Aspergillus species 
A single colony of Aspergillus species from the complete medium plate was spread as a 
lawn on a new complete medium plate. The plate was incubated at 30°C for 2 days. The spores 
were collected with 5 mL Tween 20, washed twice with sterilized water, and filtered through 
miracloth with 3 mL water. The number of spores was counted in hemocytometer under the 
microscope. 
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2.3.3 Aerobic Shake Flask 
The aerobic shake flask experiments of E. coli were performed in 250 mL shake flasks 
containing 50 mL LB medium. The medium was supplemented with the appropriate amounts of 
carbon sources and antibiotics as needed. The overnight cultures were inoculated with a final 00 
= 0.05 and grown at 25, 30 or 37°C with 250 rpm shaking. After the 00 reaches 0.4 - 0.6, the 
cultures were induced with ImM IPTG or 500 ng/f.1L arabinose as required. Samples were 
collected at various time points dependent on the experiments. 
The aerobic shake flask experiments of Aspergillus species were performed in 250 mL 
shake flasks containing 50 mL complete medium with ammonium tartrate. The cultures were 
initiated with a number of spores equal to 1.0 x 106 ImL. They were grown at 37°C with 250 
rpm. Mycelia were collected at various time points dependent on the experiments. The collected 
mycelia were filtered through miracloth and freeze-dried overnight for future use. 
2.4 Analytical Techniques 
2.4.1 Cell Density Determination (OD) 
Cell Density (00) was measured at 600 nm in a Spectronic 1001 spectrophotometer 
(Baush & Lomb). The overnight cultures were diluted to the linear range (reading between 0.1-
0.6 00600) with sterilized water in 1110 dilution. The actual cell density was calculated based on 
the reading and dilution ratio. The ODs from the samples of aerobic shaking flasks were 
measured directly without any dilution. 
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2.4.2 Extracellular metabolites analysis - HPLC 
To quantify excreted metabolites from the fermentation broth, 1 mL of culture was 
centrifuged at 13,000 rpm for 3 minutes. The supernatant was filtered through a 0.2 urn PVDF 
membrane syringe filter and stored frozen at -20°C until analysis. The extracellular metabolites, 
including the carbon sources, were quantified using a HPLC system (Shimadzu-l0A systems, 
Shimadzu, Columbia, MD). This HPLC system was connected with a cation-exchange column 
(HPX-87H, BioRad Labs, Hercules, CA), a differential refractive index (RI) detector (Water 
2410, Waters, Milford, MA) and an ultraviolet detector (UV) (Shimadzu SPD-I0A). A 2.5 mM 
H2S04 solution flowed through the system at 0.5 ml/min as a mobile phase, while the column 
was operated at 55°C. Calibration curves of standard metabolites were established for the 
interested metabolites in both RI detector and UV detector. Glucose, succinate, lactate, formate, 
acetate, and ethanol were detected in the RI detector and pyruvate, citrate, isocitrate, cis-
aconitate, trans-aconitate, and itaconate were detected in the UV detector. 
2.4.3 Enzyme Assays of CAD 
2.4.3.1 Crude Extract 
Volumes of 5, 10, or 50 mL of the E. coli cell cultures were harvested by centrifugation 
at 7000 rpm at 4 °C for 5 min. The supernatants were stored for HPLC analysis and the cell 
pellet was resuspended in the following buffer: 2.5 mM NaH2P04 pH 6.5 containing ImM DTT, 
0.1 mM EDTA, and 1 mM PMSF. The cell extracts were prepared immediately by sonicating the 
cell on ice at 50 or 75 W for 3 min with 30 sec pulse ON and OFF (Sonicator: Heat System 
Ultrasonics, Inc Model W -255). The sonicated cells were centrifuged at 10,000 rpm at 4 °C for 
10-15 min to remove cell debris. The resulting crude extracts were immediately analyzed or kept 
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at 4 °C and analyzed within the next 12 hours. Total protein concentration in cell extracts was 
analyzed with Bradford reaction (Biorad) using bovine serum albumin as standard. 
The mycelia of Aspergillus species were ground with glass beads for 3-5 minutes. The 
ground power was re-suspended in the following buffer: 20 mM Hepes pH8.0 containing 20% 
glycerol, 0.1 M KCI, 0.2 mM EDTA, 0.5 mM PMSF, and 0.5 mM OTT. The mixture was 
transferred on the ice for 15 minutes and agitated to completely suspend the protein in the buffer. 
Next, the mixture was centrifuged at 12,000 x g for 10 min at 4°C. The supernatant was further 
centrifuged at 24,000 rpm for 35 min at 4 °C. Total protein concentration in cell extracts was 
analyzed with Bradford reaction (Biorad) using bovine serum albumin as standard. 
2.4.3.2 CAD enzyme assay 
Cis-aconitate decarboxylase (CAD) activity was measured using a modification of a 
previously described method (Dwiarti et aI., 2002; Kanamasa et aI., 2008). CAD catalyzes cis-
aconitate to itaconate with the release of CO2. Cis-aconitate and itaconate were detected by 210 
nm UV detector at 9.8 min and 15.3 min, respectively. The amount of itaconate produced in the 
assay was used to determine the activity of CAD. 
2.4.3.3 Aconitase assay 
The aconitases from the experiments were activated for 30 min by Tris buffer pH 7.4 
including 40 mM Tris-HCI, 5 mM OTT, 1 mM (NH4)2Fe(S04)2, and 1 mM Na2S. (Jordan et aI., 
1999; Tsuchiya et aI., 2009) The activated aconitase was reacted with 10 mM of citrate or 
isocitrate in 50 mM Tris pH 7.4 buffers containing 1M NaCl, 5 mM OTT, and 5 mM PMSF. The 
reaction was conducted at 37°C for 30 min and quenched with 100 flL of concentrated 
hydrochloric acid. The reaction mixture was analyzed in the HPLC. By analysis with the 210 nm 
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UV detector, cis-aconitate appeared at 9.8 min in the spectra, whereas citrate and isocitrate 
overlapped at 10.3 min. The amount of cis-aconitate produced in the assay was used to determine 
the activity of aconitase. (La Nauze, 1966; Tsuchiya et aI., 2009) 
2.5 Genetic Manipulation 
2.5.1 Chromosomal DNA Purification and Plasmid Isolation 
Chromosomal DNA of E. coli was extracted using Puregene® a genomic DNA 
purification kit from Gentra Systems (Gentra Systems, Minneapolis, MN). The chromosome 
DNA was used as a template to examine the genes of interest. The chromosomal DNA from 
Aspergi/leus terreus was obtained using yeast DNA extracting kit. The chromosomal DNA from 
the fungi was used to amplity the genes of interest. Plasmids were purified using the GenElute 
Plasmid Mini-Prep kit from Sigma Aldrich by following the instructions suggested by the 
manufacturer. 
PCR products were purified using the QIAquick PCR Purification Kit (QIAGEN, 
Valencia, CA) by using the manufacturer's protocol. DNA products including digested 
fragments and PCR products in agarose gels were purified using the QIAEX II Gel Extraction 
Kit (QIAGEN, Valencia, CA) by following the attached protocol. 
2.5.2 DNA Digestion and Ligation 
Plasmid and DNA were digested by restriction enzymes obtained from New England 
Biolabs (Beverly, MA), Promega (Madison, WI), and Fisher (Pittsburgh, PA) by following the 
protocol suggested by the manufacturer. Ligation reactions were performed using the T4 DNA 
Ligation Kit from Sigma as described by the protocol. 
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2.5.3 Agarose Gel Electrophoresis 
Agarose gel electrophoresis was used to separate and verify the sizes of DNA fragments 
from either peR products or plasmid digests. The gel was prepared by mixing 1 gram of agarose 
with 100 mL of TAE buffer (40 mM Tris-acetate, 2 mM EDT A at pHS). 1 llg/mL of ethidium 
bromide or SYBR Safe DNA gel stain (Invitrogen) was added into the gel after cooling down to 
60 °e. The gel was solidified in the electrophoresis chamber and immersed in the TAE buffer 
during the electrophoresis. Samples and DNA ladders were then loaded into the gel sample 
wells, respectively. The DNA fragments were separated based on the size after applying 100 
constant volts across the gel for 1 hour. The DNA bands were visualized under the UV light, due 
to the fluorescence emitted by the added DNA dye that intercalates between the bases of DNA. 
2.5.4 peR 
Polymerase chain reaction (peR) was done to amplify the number of copies of a 
particular gene for various goals, such as to confirm insertion of a new gene, to clone an 
interested gene, or to verify correct mutations. Primers were designed for peR reactions 
following standard primer design procedures. The website http://www.idtdna.com provides 
useful tools to design the primers. Primers were designed in the idtdna website and purchased 
from Sigma Aldrich (Woodland, TX). 
peR was performed using an Eppendorf vapor protect peR machine (Hamburg, 
Germany). The Phusion High-Fidelity peR Kit from Finnzymes and the MasterTaq Kit from 
Eppendorf (Hamburg, Germany) were utilized to clone the genes by following the kit manual. 
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2.5.5 Cell Transformation 
The chemical cell transfonnation was mainly employed in this study. Chemical 
competent cells were prepared by following RbCl Transfonnation Procedure for Improved 
Efficiency (NEB Transcript, April 1994). During the transfonnation, the host cells were mixed 
with 0.1 .... g of plasmid DNA or 5-10 .... L of minipreped plasmid DNA to 100 .... L of the 
competent cells. The mixture was placed on ice for 15-30 min. Then the cells were heat-shocked 
at 42°C for 20-30 seconds. Immediately, the cells were transferred to ice and sit on ice for 5 min. 
Next, 250 .... L of SOC medium was added into the cells. The cells were incubated at 37°C at 250 
rpm for 30-45 min to allow the expression of the antibiotic resistance genes. The transfonned 
cells were selected on agar plates with appropriate antibiotic. The plates were incubated at 37°C 
overnight. 
2.5.6 Gene Cloning and Expression 
In general, the interested genes were amplified by PCR or restriction digested by certain 
enzymes. Next, the genes were ligated to vectors at the restriction sites. The ligation mixture was 
transfonned into the prepared cloning host cells and the cells bearing the possible correct 
plasmid were selected on the selection plates, using antibiotic and X-gal containing plates with 
IPTG as screens for the desired phenotype. X-gal stock is prepared at 20 mg/mL in 
dimethylfonnamide. Additionally, PCR products can also been ligated directly to the certain 
vectors, such as pTrcHis vector (Invitrogen). 
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CHAPTER 3. Expression of cad gene in various vectors in E. coli 
3.1 CAD protein expressed from pTrc99a-cad plasmid is soluble and functional in the 
cytoplasm. 
The main purpose of this experiment is to determine whether the CAD protein can be 
expressed and functional in the cytoplasm. Based on published cad gene sequence (Kanamasa et 
aI., 2008), the synthetic cad gene was ordered and inserted into the pTrc99a vector. This plasmid 
was transformed into E. coli strains with either acnA or acnB mutation or wild type, individually. 
As experimental controls, the host plasmid pTrc99a without the cad gene was also transformed 
into the same three E. coli strains. The overnight cultures of these strains with either pTrc99a-
cad or pTrc99a plasmid were inoculated in new flasks containing 50 mL LB medium with 50 
mM glucose. After the induction of gene expression from the plasmid for 4 hours with 1 mM 
IPTG, the expression of CAD in the cell lysate was analyzed using the CAD enzyme assay 
(Dwiarti et aI., 2002). The production of IA from the supernatant was also examined by High 
Performance Liquid Chromatography (HPLC). The concentration of IA produced from both the 
assay and the supernatant of cell cultures was determined by comparison with a standard curve 
ofIA run on the HPLC. 
As shown in Figure 3.1, by analysis using the 210 nm UV detector, cis-aconitic acid 
(Sigma) displays a peak at 8.717 minutes, while itaconic acid (Sigma) is detected at 15.437 
minutes. Citric acid and isocitric acid (Sigma) overlap each other at 9.973 minutes in the 
spectrum. RID detector is not sensitive to trace the amounts of metabolites listed above. 
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1 - 250 u1 2 mglml aconitate 
2 - 250 u1 10m&fml citrate 
250 u1 10mglmllS0Cttrate 
ak 3 - 250 u1 2 mglml itaconic acid 
Figure 3.1 - HPLC spectrum of standard organic acids under 210 nm UV detector. 
Peak 1 - 250,....L 2mg/ml aconitic acid; Peak 2 - overlap of 250,....L 10mg/ml citric acid and 
250,....L 10mg/ml isocitric acid; Peak 3 - 250,....L 2mg/ml itaconic acid. 
In the spectrum Figure 3.2-1, cis-aconitic acid existed in excess as indicated by the large 
peak at 8.947 minutes. Importantly, a small peak at 15.443 minutes should show the production 
of itaconic acid, which was not found in either the positive or negative controls (Figure 3.2-II & 
III). The biological control was E. coli strai.n bearing pTrc99a vector without the cad gene, while 
the negative control is just the reagents for the CAD enzyme assay without the enzyme. These 
results indicate the cad gene was expressed under the induction of IPTG and CAD protein is 
soluble in the cytoplasm. More importantly, these results suggest that CAD protein is functional 
to catalyze the decarboxylation of cis-aconitate during the reaction. Meanwhile, a small level of 
IA (0.263 mM or 34.19 mg/L) was detected in the supernatant from the strain bearing cad gene 
relative to the control, as indicated by the yellow arrow in the spectra (Figure 3.3). This result 
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further confirms the activity of CAD. But the production rate of IA is so small that a higher 
expression rate of CAD with better activity was highly recommended. 
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III 
Figure 3.2 - Comparison of HPLC profiles from cis-aconitic acid assays. 
( I ) - Ix crude protein extract from GNB 11339 .dacnA::KmR pTrc99A:cad; ( II ) - Ix crude 
protein extract from GNB 11339 .dacnA::KmR pTrc99A; (III) - reagents for cis-aconitic acid 
assays. Yellow arrow indicates the retention time for IA in HPLC under 210 nm UV detector. 
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Figure 3.3 - Comparision of the content~ of supernatants in HPLC after 1 day incubation 
for GNB 11339 AacnA:KMR pTrc99A:cad (I) and the control GNB 11339 AacnA:KMR 
pTrc99A (II). 
The supernatants of cell cultures after 1 day incubation were analyzed by HPLC. Yellow arrow 
indicates the retention time for IA in HPLC. 
3.2 CAD protein expressed from pTrcHis-cad vector was functional and visualized through 
Western Blot. 
The main goal of constructing pTrcHis-cad plasmid is to purify the CAD protein with 
His-tag and to further characterize the functions and expressions level of the CAD protein. I 
inserted the cad gene into pTrcHis vector (Invitrogen) and verified the construct by restriction 
digest and sequencing (See Figure 3.4). With the induction of lmM IPTG, the expression of cad 
gene was analyzed by a CAD enzyme assay in vitro. The CAD activity in the cell crude was 
identified by the appearance of itaconate in HPLC. The crude protein was further purified 
through QIAGEN Ni-NTA mini-column (QIAGEN) with centrifugation. The purified protein 
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was immune-precipitated by primary anti-His antibodies and detected with a secondary antibody 
in a Western Blot. As shown in Figure 3.5, without induction of IPTG, no strong bands were 
visualized in the lanes of the eluates, which were collected from each step of Ni-NTA mini-
column purification using GNB11339 pTrcHis-cad cell crude lysate. In contrast, in extracts 
made form cells with induction of IPTG, a strong band from 1st eluate of GNB11339 pTrcHis-
cad was visualized on the membrane. This band was expected to be the protein, (His )6-CAD, 
which should have a size of 59kDa based on the published data. (Dwiarti et aI., 2002; Kanamasa 
et aI., 2008) Additionally, the 1 st eluate from the induced GNB 11339 pTrcHis-cad strain also 
displayed some activity in the CAD enzyme assay. However, the low resolution of this band may 
indicate that the amount of CAD protein in the cell crude is relatively low. Lower temperature 
and longer incubation time have been suggested to increase the expression and improve folding 
of (His )6-CAD protein. 
Begining point 
5306Ap81 
/ 425ATG 
°moter x Istag 
............ IL n3Apa' 
,/ 
ptrcHis-CAD 
vector 
6248 bp 
Figure 3.4 - Plasmid map of pTrcHis-cad. 
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Figure 3.5 - Western blot of eluates from GNBl1339 pTrcHis-cad with & without 
induction of ImM IPTG during Ni-NTA mini-column purification. 
After sonication, cell crude extract was separated from cell debris by centrifugation. Cell crude 
extract was subjected to Ni-NTA column using a centrifugation protocol. (His)6-CAD attached to 
the Ni-NTA column; the rest of the cell crude extract was called flow through (flow thru) and 
collected. After washing the column twice to remove the contaminants, (His)6-CAD was eluted 
by eluting buffer containing a high concentration of imidazole. The first collection was 1 st eluate. 
3.3 Expression of cad gene in other high-copy plasmids was not successful. 
The main goal of building the following plasmids is to further enhance the amount of 
CAD protein in the expression and characterize the CAD enzymatic activity. The cad gene was 
also cloned into various vectors: pDHC29, pET-32a, and pThioHisB. Each construct was 
confirmed by PCR and sequencing. The purpose of constructing pDHC29-cad plasmid (Figure 
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3.6) was to over-express cad gene in a chloramphenicol resistant plasmid, which is highly 
compatible with other high copy number plasmids (Phillips et aI., 2000). Unfortunately, no 
activity of CAD from pDHC29-cad plasmid was shown in the enzymatic assays. To over-express 
and characterize CAD protein, I attempted to insert cad gene into pET-32a vector (Figure 3.7). 
No significant activity of CAD was detected in the enzymatic assay of cell extracts made from 
the induced cells, either. Meanwhile, only small amount of CAD activity was detected from cells 
bearing the pThioHisB-cad plasmid (Figure 3.8). Several reasons may contribute to low activity 
or no function of CAD. First of all, in these constructs, a long extra protein tail from each vector 
has usually been inserted in front of actual CAD protein sequence. This long tail may affect the 
proper folding of the protein, causing its malfunction. Secondly, growth conditions may not be 
proper for proper folding. Although I tried to grow the cells at lower temperatures, such as 30°C 
and 25°C, no significant improvement of CAD activity was observed in the enzymatic assay. 
Thirdly, my colleagues mentioned that since CAD protein originated from fungus, over-
expression of the gene in high copy plasmids may lead to aggregation of the protein. That may 
explain why no significant activity was detected in the enzymatic assay. Therefore, future work 
will be necessary to solve these problems. 
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CAT marker pDHC29-CAD 
vector 
5074 bp 
Figure 3.6 - Plasmid map of pDHC29-cad 
Pstl 
The cad gene was inserted into pDHC29 vector at Pst! and SaIl sites. 
S811 
pET32a-CAD 
vector 
7694 bp 
Figure 3.7 - Plasmid map of pET -32a-cad 
Ncol 
The cad gene was inserted into pET -32a vector at Neol and SaIl sites. 
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CAD P ThioHisB-CAD 
vector 
5888 bp pUC ori 
Figure 3.8 - Plasmid map of pThioHisB-cad 
The cad gene was inserted into pThioHisB vector at Nco I and Sail sites. 
3.4 Comparison of expression of constructed plasm ids in various strains using different 
carbon sources 
To systematically compare the expression of the cad gene from various vectors, the 
strains GNB 11339 (~acnA:KmR) , GNB 11315 (Chromosomal P ara-groELIS), and GNB 11321 
(Chromosomal P AlIlaco-l-dnaKlJ-lacfl) were employed to characterize the expression rate of cad 
gene. GNB 11339 is the strain MG 1655 with an acnA mutation; without acnA, the CAD protein 
is expected to have more accessibility to cis-aconitate. Meanwhile, acnB is the main aconitase 
expressed during the exponential growth of E. coli; hereby, acnB is necessary for growth during 
the new inoculation of overnight cultures. GNB 11315 and GNB 11321 are both heat shock 
chaperone over-expression strains. Over-expression of heat shock protein would be expected to 
improve the folding of the CAD protein. If the experiments were successful, I would expect 
more IA in the supernatant would be formed by GNB11339 strain because only the acnB protein 
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competed with the CAD protein for cis-aconitate. The CAD protein has more opportunities to 
decarboxylate the cis-aconitate in the cytoplasm. Since heat shock protein usually improves the 
protein folding, a higher activity of the CAD protein would be expected in the CAD enzyme 
assay in vitro because more active CAD protein would be formed under the assistance of heat 
shock protein. As a result, a higher amount of IA in the supernatant would be expected due to the 
presence of more active CAD protein. 
These strains bearing the plasmids were grown aerobically under the same conditions. 
Their ODs were measured to be identical when aliquots of cultures were taken. The supernatants 
were analyzed in the HPLC to determine the production yield of itaconate. Meanwhile, the cis-
aconitate and citrate were utilized as the sole carbon sources to demonstrate the activity of CAD 
in vivo. 
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Figure 3.9 - Comparison of supernatant contents of various E. coli strains bearing different 
plasm ids after 24 and 48 hrs incubation at 30°C. 
During the aerobic inoculation, cis-aconitate was served as the sole external carbon sources. 
GNB11339 pTrc99a strain was used as experimental control. 
In Figure 3.9, it is clear that GNB 11339 pTrc99a-cad generated the highest amount of IA 
at each time point. As a control, GNB11339 pTrc99a with the cad insert didn't produce any IA 
as expect. Interestingly, in the same E. coli strain GNB11339, the enzyme expressed from 
pTrc99a-cad plasmid seemed to display higher catalytic activity than one from pTrcHis-cad. 
Moreover, various strains bearing the same pTrcHis-cad plasmid displayed different production 
rates of IA at each time period. But the strain GNB 11339 was preferred since a higher amount of 
IA was generated. Surprisingly, the chaperone over-expression strains (GNB 11315 and 
GNB11321) didn't improve IA production rate in the batch. These results suggest that pTrc99a-
cad plasmid was a better one to express high active CAD protein and the ~acnA mutant may 
provide advantages to E. coli in producing IA. Additionally, pThioHisB-cad may not express 
3S 
CAD activity at all since the amount of IA detected in the assays of cells bearing this construct is 
so low in the supernatant. 
To further confinn the results obtained from the previous trial, strains bearing various 
plasmids were tested in a new experiment. In this experiment, citrate replaced cis-aconitate as the 
carbon source because I wish to prove the previously verified route in a small scale: citrate~ cis-
aconitate~ itaconate. The strains GNBI1339 pTrc99a and BL21 were used as positive controls, 
while LB medium with citrate served as a negative control. The supernatant of each strain from 
24 hrs incubation cultures was analyzed in HPLC. As shown in Figure 3.10, the strain 
GNB 11339 pTrc99a-cad still displayed the highest yield of IA as expected. The highest amount 
of IA yield from pTrcHis-cad vector was also obtained from GNB11339 strain. This result 
further suggests the AacnA mutant allows CAD to compete more fiercely for cis-aconitate inside 
the cell. 
Interestingly, the strain GNBI1321 pThioHisB-cad displayed a better yield of IA than 
GNB 11339 strain bearing the same plasmid. This result suggests that the over-expression of 
chaperon may increase the activity of enzyme. Additionally, the strain BL21 pET32a & pT -GroE 
also produced small quantity of IA. In summary, the plasmid pTrc99a-cad had presented the best 
yield of IA production in E. coli strain and the AacnA mutant improved the production rate of IA 
during the fennentation. 
Furthennore, the data from both trials indicate that using cis-aconitate and citrate as the 
carbon sources, E. coli strains generated higher production of IA than ones using glucose (data 
not shown). This phenomenon was reasonable because cis-aconitate in the medium could be 
directly catalyzed by CAD and citrate could be converted to cis-aconitate more easily than 
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glucose. This result somehow illustrated the previously identified pathway: citrate7 cis-
aconitate7 itaconate. 
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Figure 3.10 - Comparison of supernatant contents of cultures of various E. coli strains 
bearing different plasm ids at 24 hrs incubation. 
During the aerobic incubation, 60 mM citrate served as the sole external carbon sources. 
GNB11339 pTrc99a and BL21 strains were used as experimental controls and LB medium with 
citrate was used as negative control. 
To compare the activity of CAD expressed from pTrcHis-cad and pTrc99a-cad in vitro, 
the strains TOPI0 and GNB11321 were employed as the hosts. The cells were grown aerobically 
with or without induction of IPTG. Then after 4 hrs incubation, the cells were subject to 
sonication and cell lysates were analyzed in the CAD enzyme assay. As shown in the Figure 
3.11, with induction of IPTG, the CAD expressed from pTrc99a-cad showed significantly higher 
activity than the one from pTrcHis-cad. This result further supports the previous conclusion that 
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pTrc99a-cad plasmid was a better one to express high active CAD protein, leading to the high 
yield of IA production in E. coli strains. 
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Figure 3.11 - Comparison of CAD activities from TOP10 and GNBl1321 strains bearing 
either pTrc99a-cad or pTrcHis-cad under the presence or absence of 1mM IPTG. 
The unit (mM/mg/min) is defined as 1 mM of IA produced from 1 mg of cell crude in the cis-
aconitate enzymatic assay per min. 
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CHAPTER 4. Exploring the potential aconitase gene from Aspergillus species 
and Shewanella oneidensis 
4.1 No "citrate dehydratase" existed in the supernatant of Aspergillus niger (A. niger). 
The main purpose of this experiment is to determine whether "citrate dehydratase" exists 
in the fungus to catalyze only between citrate and cis-aconitate. As mentioned in the background, 
"citrate dehydratase" was identified in Aspergillus niger strain 72-4. (Neilson, 1955, 1956) But 
La Nauze disproved Neilson's conclusions and showed that aconitase in A. niger strains 72-4 
could both interconvert citrate or isocitrate to cis-aconitate. (La Nauze, 1966) However, it is 
ambiguous to determine whose conclusions are correct. 
In this project, Aspergillus niger DSM872, which is closed to the strain used by Neilson, 
was grown for 2 days. Mycelia were filtered, freeze-dried, and grinded up in Hepes buffer. The 
ammonium sulfate procedures (Neilson, 1956) were utilized to precipitate the "citrate 
dehydratase" in cell crude. After dialysis of the enzyme, the activity of proteins from 25% to 
42% ammonium sulfate saturation was analyzed in the aconitase assays. (La Nauze, 1966) 
According to Neilson, the 25% - 42% fraction displayed 48 times higher conversion rate in 
catalyzing cis-aconitate-?citrate than cis-aconitate -?isocitrate. However, in my study, when 
either 10mM citrate or isocitrate was utilized in the aconitase assay, the same quantity of cis-
aconitate (0.008 mM) from the reaction mixture was detected in HPLC using a 210nm UV 
detector (see Figure 4.1). People may observe that aconitases from various species display higher 
Km for citrate than isocitrate (Brenda Enzyme) so that a lower amount of citrate was converted 
into cis-aconitate. But the proposed citrate hydratase should overcome this limitation to produce 
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more cis-aconitate since plenty of citrate was used in the aconitase assay. This result really raised 
the question about the existence of citrate hydratase in the publication of Neilson or there is a 
significant difference in the strain used. 
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Figure 4.1 - Comparison of HPLC profiles from the aconitase assays of the 250/0-420/0 
fraction of Aspergillus niger cell crude. 
( I ) - The activated 25%-42% fraction reacts with 10mM citrate; ( II ) - The activated 25%-42% 
fraction reacts with 10mM isocitrate. Yellow arrow indicates the retention time for cis-aconitate 
in HPLC under 210 nm UV detector. 
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4.2 Explore the candidate aconitase genes from Aspergillus terreus NIH2624 
Since no progression was made to identify the desired aconitase from Aspergillus niger, 
I planned to directly clone the aconitase genes from A. terre us by peR. As mentioned in the 
introduction, bioinformatic analysis revealed four candidate aconitases gene from A. terreus 
NIH2624: ATEG_03325 (mitochondrial precursor) and ATEG_08913 (cytosolic precursor) 
under non-itaconic acid producing conditions; ATEG_02937 (mitochondrial precursor) and 
ATEG_05743 (cytosolic precursor) under itaconic acid producing conditions. To clone these 
genes, the mycelia of A. terreus NIH2624 were collected from 2 day incubation in eM medium 
with ammonium tartrate. The genomic DNA was extracted from the mycelia using the 
MasterPure™ Yeast DNA Purification kit (Epicentre Biotechnologies). Next, primers were 
designed to remove the introns from each gene. 
4.3 Mitochondrial aconitate hydratase (ATEG_02937) from Aspergillus terreus NIH2624 
was cloned into pTrc99a vector. 
Three sets of primers were designed to clone the coding exons of ATEG_02937 gene 
from genomic DNA of Aspergillus terreus NIH2624; another set of peR were performed to join 
all the coding exons and amplify the entire gene. The gene ATEG_02937 was annotated as 
"mAcn-ita" The cloned gene was successfully inserted into pTrc99a vector (Figure 4.2). Finally, 
the sequencing result reveals that the cloned gene matches exactly with the sequence of 
ATEG_02937 gene. 
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pBR322 
p Trc99a-mAcn-ita 
vector 
7443 bp 
\ 
\ 
'· Xbal 
Figure 4.2 - Plasmid map of pTrc99a-mAcn-ita. 
mAcn-ita 
ATEG_02937 gene (mAcn-ita) will be inserted at EcoR! and Xbal sites. 
Next, the plasmid pTrc99a-mAcn-ita was transformed into GNB 11338 and GNB 11339, 
respectively, while the vector pTrc99a was transformed into both strains as controls. All the 
strains grew in LB medium with 50 mM glucose under the same conditions in the aerobic 
shaking flask. After induction of IPTG, the supernatant of each strain was collected and analyzed 
at three time points: 4, 24, and 48 hours. As shown in Figure 4.3-1, comparing to the control, 
GNBl1338 pTrc99a-mAcn-ita displayed a large peak at 10.3 min in the supernatant after 4 hours 
induction. However, after 24 and 48 hours induction, the peak at the same retention time from 
GNB11338 pTrc99a-mAcn-ita diminished to the same size as the peak at 10.3 min from the 
control GNB11338 pTrc99a. Meanwhile, comparing the supernatants from GNB11339 pTrc99a-
mAcn-ita and GNB 11339 pTrc99a, GNB 11339 pTrc99a-mAcn-ita also displayed a large peak at 
10.3 min after 4 hours induction. Interestingly, after 24 and 48 hrs induction, the peak at the 
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same retention time from GNBl1339 pTrc99a-mAcn-ita also decreased to the same size as the 
peak at 10.3 min from the control GNB11339 pTrc99a (data not shown). All of these results 
strongly suggest that pTrc99a-mAcn-ita may be functional to express the inserted gene and the 
expressed mAcn-ita protein should be soluble in the cytoplasm. More importantly, this protein 
directly influences the content of metabolites at early stage after the induction. 
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Figure 4.3 - Comparision of supernatants of GNBl1338 pTrc99a and GNB11338 pTrc99a-
mAcn-ita in HPLC. 
The supernatant of each strain was collected after 4 hrs (I), 24 hrs (II), and 48 hrs (III) induction 
of IPTG. The black line represents the supernatant of GNB11338 pTrc99a; the pink line 
represents the supernatant of GNB 11338 pTrc99a-mAcn-ita. Yellow arrow indicates the 
important peak at 10.3 min in HPLC. 
4.4 Mitochondrial aconitate hydratase (ATEG_03325) and cytosolic aconitate hydratase 
(ATEG_08913) from Aspergillus terreus NIH2624 were cloned into pTrc99a vector, too. 
Using the similar methods as cloning the gene ATEG_02937 from A. terreus NIH2624, 
five sets of primers were designed to clone the coding exons of A TEG _03325 gene, while eight 
pairs of primers were ordered to amplify the coding exons of ATEG_08913. For both genes, 
another trial of PCR was performed joined all the coding exons and amplified the entire gene. 
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The cloned gene was successfully inserted into pTrc99a vector and verified by sequencing (see 
Figure 4.4 and 4.5). Likewise, the plasmid pTrc99a-ATEG_03325 and pTrc99a-ATEG_08913 
were transformed into GNB 11338 and GNB 11339, respectively, while the vector pTrc99a was 
transformed into both strains as controls. All the strains grew under the same conditions in the 
aerobic shaking flask. After induction of IPTG, the supernatant of each strain bearing each 
plasmid was collected at three time points: 4, 24, and 48 hours, and then analyzed in HPLC as 
before. 
pBR3220ri 
pTrc99a-ATEG03325 
vector 
6501 bp 
ATEG03325 
Figure 4.4 - Plasmid map ofpTrc99a-ATEG03325. 
The gene A TEG _ 03325 was inserted into pTrc99a vector at EcoR! and XbaI sites. 
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p Trc99a-ATEG08913 
vector 
6591 bp 
ATEG08913 
Figure 4.5 - Plasmid map of pTrc99a-ATEG08913. 
The gene ATEG_08913 was inserted into pTrc99a vector at Ncol and Xbal sites. 
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Figure 4.6 - Comparision of metabolite contents of supernatants from the strains 
GNBl1338 pTrc99a, GNBl1338 pTrc99a-ATEG03325, and GNBl1339 pTrc99a-
ATEG08913 in HPLC. 
The supernatant of each strain was collected after 4 hrs (I), 24 hrs (II), and 48 hrs (III) induction 
of IPTG. The black line represents the supernatant of GNBl1338 pTrc99a; the pink line 
represents the supernatant of GNB11338 pTrc99a-ATEG_03325; the blue line represents the 
supernatant from GNB11338 pTrc99a-ATEG_08913. Yellow arrow indicates the important peak 
at 10.3 min in HPLC. Red arrow indicates the important peak at 16.1 min in HPLC. 
As shown in Figure 4.6-1, after 4 hrs induction of IPTG, GNB11338 bearing either 
pTrc99a-ATEG_03325 or pTrc99a-ATEG_08913 displayed a large peak at 10.3 min in the 
supernatant comparing to the control GNB11338 bearing the vector pTrc99a. Meanwhile, the 
peak at 10.3 min from GNBl1338 pTrc99a-ATEG_08913 is much stronger than one at the same 
retention time from GNB 11338 pTrc99a-ATEG _03325. Interestingly, GNB 11338 bearing 
pTrc99a-ATEG_08913 also showed a big peak at 16.1 min in comparison to GNB11338 bearing 
either pTrc99a-ATEG_03325 or pTrc99a. However, after 24 and 48 hrs induction, the peak at 
10.3 min from both GNBl1338 pTrc99a-ATEG_03325 and GNBl1338 pTrc99a-ATEG_08913 
so 
decreased to the same size as the peak at same retention time from the control GNB11338 
pTrc99a. In addition, a peak at 16.1 min from GNBI1338 bearing pTrc99a-ATEG_08913 also 
reduced to the same intensity as the peak from GNBI1338 bearing either pTrc99a-ATEG_03325 
or pTrc99a after 24 and 48 hrs induction. 
Meanwhile, comparing the supernatants from GNB11339 pTrc99a-ATEG 03325, 
GNBI1339 pTrc99a-ATEG_08913 and GNBI1339 pTrc99a, GNBI1339 strain expressing the 
cloned aconitase genes also displayed a large peak at 10.3 min in contrast to the control 
GNBI1339 pTrc99a after 4 hours induction. Interestingly, after 24 and 48 hrs induction, the peak 
at the same retention time from GNB 11339 strain bearing either pTrc99a-A TEG _ 03325 or 
pTrc99a-ATEG_08913 also decreased to the same size as the peak at 10.3 min from the control 
GNBI1339 pTrc99a (data not shown). In addition, GNBI1339 pTrc99a-ATEG_08913 also 
displayed a big peak at 16.1 min after 4 hrs induction comparing to the other two strains. The 
peak at 16.1 min from GNBI1339 pTrc99a-ATEG_08913 decreased to the similar size as the 
other two strains after 24 and 48 hrs induction. 
All these results suggest that both ATEG_03325 and ATEG_08913 proteins are soluble 
and functional in the cytoplasm of host cells. They both affected the content of metabolites in the 
early induction phase. More interestingly, ATEG 08913 protein seems to have a stronger 
influence than ATEG_03325. 
4.5 No activity of CAD was observed from the strains bearing pPRP140-cad plasmid. 
As shown in Table 2, acnD codes for a 2-methylcitrate dehydratase that seems to only 
catalyze the inter-conversion of citrate and cis-aconitate under the assistance of PrpF protein 
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(Grimek and Escalante-Semerena, 2004). It means that less cis-aconitate will be degraded to 
isocitrate so that cis-aconitate can be accumulated as the substrate for CAD. We were grateful to 
receive the plasmid pPRP140 coding for both AcnD and PrpF proteins from Dr. Escalante-
Semerena. The plasmid was verified by restriction digests and sequencing. Initially, I 
transformed both pPRP140 and pDHC29-cad into the wild type strain. After induction of 
pDHC29-cad, no activity of CAD was detected using the cis-aconitate assay. 
Alternatively, I digested the pTrcHis-cad vector to excise the fragment containing the cad 
gene and Lac Repressor (lacIQ), and then ligated the purified fragments into pPRP140. The new 
constructed plasmid was analyzed by PCR and confirmed by sequencing (Figure 4.5). Next, I 
transformed this plasmid into the parental strains. After induction of the acnD, prpF, and cad 
gene from the plasmid, I tested the activity of CAD expressed from this new plasmid. As an 
experimental control, the same parental strains bearing the pPRP140-cadwere incubated without 
the induction of plasmid overtime. As a control, the same parental strains bearing the pTrcHis-
cad plasmid were used for the comparison. In the CAD enzyme assay, no significant CAD 
activity was detected. This result indicates that the new construct may not function properly or 
the growth conditions were not optimal for the protein folding. More work will be needed to 
trouble-shoot the problems. 
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Figure 4.7 - The gene map ofpPRP140-cad. 
AcnD 
The plasmid is ampicillin resistant and originates from the pBAD30. The acnD and prpF genes 
are induced by arabinose, whereas the cad gene IS induced by IPTG. 
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Chapter 5. Conclusions 
Recent studies have examined the potential of E. coli as a host to produce itaconic acid. 
Itaconic acid is a valuable renewable chemical used frequently in the medicine, pharmacy, and 
industry. Previous studies have verified the metabolite pathway of IA production and revealed 
the unique characteristics of cis-aconitate decarboxylase (cad) gene. In this study, I explored the 
expression of cad gene in E. coli. The CAD enzyme is soluble in the cytoplasm and active in 
catalyzing cis-aconitate to itaconate both in vitro and in vivo. Various vectors, including 
pTrc99a, pTrcHis, pDHC29, pET32a, and pThioHisB, were employed to over-express cad gene. 
So far, highest amount of IA from supernatant and best activity of CAD in vitro were obtained 
from the strains bearing pTrc99a-cad plasmid. The mutation of the acnA or acnB gene in the host 
E. coli seems to improve the production of IA comparing to the wild type strains. In particular, 
when 60mM citrate was utilized as the sole carbon source in the batch, the strain GNB 11339 
bearing pTrc99a-cad yielded highest amount of IA in the supernatant. 
The low supply of cis-aconitate in the cytoplasm is one limitation in this project. To 
enhance the conversion of citrate to cis-aconitate, the candidate genes of aconitases from 
Aspergillus terreus were explored in the project. The mitochondrial and cytosolic aconitate 
hydratases (ATEG_02937, ATEG_03325 and ATEG_08913) have been successfully cloned and 
expressed from pTrc99a vector. After four-hour induction of IPTG, the strong peak at 10.3 min 
appeared in the supernatant from the strains expressing the aconitate hydratases. However, after 
a long time induction, this strong peak abated to the same concentration as the peak observed in 
the control. Surprisingly, the strain GNB11338 pTrc99a-ATEG_08913 also showed a big peak at 
16.1 min at the early induction stage. Therefore, all cloned aconitases are active in catalyzing the 
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metabolites inside the cytoplasm. Although I haven't identified the content of this large peak at 
10.3 min in HPLC, it is certain that the cloned genes stressed expression of certain metabolites in 
various degrees. If the peak at 10.3 min is verified to be cis-aconitate, this obtained data will 
support my hypothesis that certain aconitases from A. terreus could accumulate significant 
amount of cis-aconitate inside the cytoplasm. Consequently, I expect that a higher amount of IA 
will be achieved when high levels of CAD protein is co-expressed with this aconitase in the E. 
coli. In addition, I would like to continue to analyze the expression of the rest of aconitase genes 
to determine whether they can also enhance the production of cis-aconitate. 
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Appendix A 
Complete medium for Aspergillus species From Dr. Greg May's Lab at MD Anderson 
Cancer Center in Houston, TX 
Minimal Medium 
SOX MM Salts 
Component 
NaN03 
KCI 
MgS04:7H20 
Amt.lLiter 
300 gram 
26 gram 
24.6S gm 
Dissolve each in the order given and store at room temperature over a few drops of chloroform. 
1M Phosphate Buffer pH-6.8 
Component 
Making Minimal Medium (MM) 
Component 
SOX Salts 
Dextrose 
1M KP04 pH6.8* 
Trace Elements 
Agar 
Complete Medium (CM) 
Add the following to MM. 
Component 
Yeast Extract 
Peptone 
Tryptone 
Vitamin Mix 
CM Supplement 
Amt.lLiter 
68gm 
87.1 gm 
Amt.lLiter 
20ml 
10 gm for plates or 3.6 gm for liquid 
12 ml* Add after autoclaving for liquid media to prevent 
precipitate forming. 
1 ml 
12.S gm For solid media 
Amt.lLiter 
Igm 
2gm 
19m 
2ml 
10 ml 
60 
Greg's Modified Trace Elements 
Component 
0.25 M EDT A pH8.0 
FeS04:7H20 
ZnS0 4:7H20 
CuS04:5H20 
MnS04:H20 
Na2B407: 1 OH20 
NaMo04:2H20 
CaCh:2H20 
AmtlLiter 
100 ml 
Igm 
8.8gm 
0.4 gm 
0.15 gm 
0.1 gm 
0.1 gm 
0.1 gm 
mM 
25 
3.6 
30.1 
1.6 
0.89 
0.26 
0.41 
0.68 
Dissolve each in the indicated order being sure that the first is fully dissolved before adding the 
next. This is 1000 fold concentrated. Store the mixture at room temperature. 
VITAMIN MIX 
Component 
p-Aminobenzoic acid 
Niacin 
Pyridoxine HCI 
Riboflavin 
Thiamine HCI 
Choline HCI 
d-Biotin 
Amt.lLiter 
Igm 
Igm 
1 gm 
Igm 
Igm 
Igm 
2mg 
Store at 4°C in the dark after autoclaving. 
CM SUPPLEMENT 
Component 
Adenine HCI 
L-Methionine 
L-Lysine or Arginine 
Riboflavin 
Amt.lLiter 
5gm 
5gm 
36.5 gm 
0.5 gm 
Store at 4°C in the dark after autoclaving. 
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